Tolerability & Safety of Premarin Vaginal Cream in Indian Postmenopausal Women

Completed

• Conditions: Postmenopause

• Registration Number: NCT00484107
• Lead Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer

Brief Summary

This post-marketing study will provide local safety and tolerance data on the use of Premarin® vaginal cream.

Detailed Description

Not available

Study Timeline

• Study Start: 2005-09
• Study Completion: 2006-10
• Study First Submitted: 2007-06-07
• Study First Submitted QC: 2007-06-07
• Study First Posted: 2007-06-08
• Status Verified: 2007-12
• Last Update Submitted: 2007-12-20
• Last Update Posted: 2007-12-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 200

Inclusion Criteria

• Patients in whom Premarin vaginal cream is indicated.
• In the opinion of the investigator, sufficient intelligence and motivation for the patient to continue throughout the study.
• Provide signed informed consent.

Exclusion Criteria

• Patients not willing to give informed consent.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified